Close this search box.

Seventeen Minutes of Science: Viral Gene Therapies and Their Potential Use Against COVID-19

Tune in weekly to our virtual series “Seventeen Minutes of Science” every Tuesday at 11am PST / 2pm ET where we go live on Facebook with a new guest each week to talk about how science and biotechnology is woven into their lives for (you guessed it) 17 minutes!

This week on 17 Minutes of Science we are joined by Mark Mendoza. Mark currently works at the Fred Hutch Cancer Research Center in Seattle where his work primarily focuses on gene therapies, and has spent most of his career helping translate therapies.

Viral gene therapies have a plethora of applications for healthcare, and are currently being looked at as an option in the fight against COVID-19.

Join us as we discuss with Mark Mendoza about viral gene therapies in relation to COVID-19.

About The Author

InVivo Biosystems

InVivo Biosystems provides essential services to help pharmaceutical, nutraceutical, biotechnology companies and academic research institutions around the globe accelerate their research and drug development efforts. An expert in CRISPR genome editing, InVivo Biosystems creates custom genome edited C. elegans and zebrafish models to enable aging and other disease studies. In addition, InVivo Biosystems provides in-vivo analytical services to produce data and insights for companies that need to make go/no-go decisions quickly in early-stage development of new compounds.

Share this articles

Picture of InVivo Biosystems

About the Author:

Connect with us